Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 11Recruiting 7Terminated 2Not yet recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Infertility 2Anovulation 2

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interventional × Medroxyprogesterone Acetate × Clear all
NCT01718444 2020-09-29

Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)

University of Illinois at Chicago

Phase NA Terminated
27 enrolled

Anovulation, Infertility, Polycystic Ovary Syndrome

NCT01607320 2018-09-20

PCOS

Prisma Health-Upstate

Phase NA Terminated
3 enrolled 3 charts

Anovulation, Infertility, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡